All Reports

Global Pharmaceutical Isolators Market (High-value & Low-value): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

Date: 23, June 2022 | Pages: 87 | Price : $1400 | Format : Pdf

The global pharmaceutical isolators market is expected to record a value of US$2.42 billion in 2026, growing at a CAGR of 11.25%, for the time period of 2022-2026. Factors such as expansion of biotechnology industry, explosive growth of cell & gene therapies in development, increasing use of high potency active pharmaceutical ingredients, rising focus on contract development manufacturing o ..

US Biosimilar Market: Insights & Forecast with Potential Impact of COVID- 19 (2022-2026)

Date: 23, June 2022 | Pages: 108 | Price : $1250 | Format : Pdf

The US biosimilar market is forecasted to reach US$36.16 billion in 2026, experiencing growth at a CAGR of 40.16% during the period spanning from 2022 to 2026. Growth in the US biosimilar market is supported by factors such as rising prevalence of cancer, growing geriatric population and favorable environment. However, the market growth is expected to be restrained by complexities in manufactur ..

China Online Healthcare Market: Insights & Forecast with Potential Impact of COVID- 19 (2022-2026)

Date: 12, June 2022 | Pages: 84 | Price : $1250 | Format : Pdf

China online healthcare market is forecasted to reach US$311.48 billion in 2026, experiencing growth at a CAGR of 36.89% during the period spanning from 2022 to 2026. Growth in China online healthcare market is supported by factors such as aging population, rising health expenditure, support from Chinese government, technical innovations and rising internet penetration. However, the market grow ..

China TAVR & TMV Market: Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

Date: 7, June 2022 | Pages: 74 | Price : $1250 | Format : Pdf

China TAVR market is expected to reach US$1,669.14 million in 2026, growing at a CAGR of 55.50%, for the duration spanning 2022-2026. While, the TMV market in China is forecasted to reach US$741.24 million in 2026, rising at a CAGR of 147.16%, for the time period of 2022-2026. Factors such as growing prevalence of aortic stenosis, rise in approval of new TAVR products, rise in geriatric populat ..

Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID- 19 (2022-2026)

Date: 3, June 2022 | Pages: 127 | Price : $1800 | Format : Pdf

The global radiation therapy market is expected to reach US$12.44 billion in 2026, witnessing growth at a CAGR of 6.75%, over the period 2022-2026. Factors such as surging incidence of cancer cases, rising healthcare expenditure, upsurge in economic growth, growing aging population and expanding urbanization are expected to drive the market. The growth of the market would be challenged by sever ..

Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

Date: 15, April 2022 | Pages: 106 | Price : $1400 | Format : Pdf

The global plasma derived therapy market is anticipated to reach US$50.70 billion in 2026, growing at a CAGR of 7.20% during the period spanning 2022-2026. The growth in the market has been driven by factors like rising geriatric population, increasing prevalence of genetic disorders, government initiatives, rising demand for albumin, escalating use of plasma proteins in pharmaceuticals, increa ..

China Biological Reagents Market (Molecular Biology Reagents, Proteins and Cell Reagents): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

Date: 6, April 2022 | Pages: 86 | Price : $1250 | Format : Pdf

The China biological reagent market is forecasted to reach US$6.39 billion in 2026, experiencing growth at a CAGR of 14.87% during the period spanning from 2022 to 2026. Growth in the China biological reagent market was supported by factors such as increasing research in the field of life sciences, technological innovations, rising number of genome projects, rising incidence of genetic disorder ..

U.S. Managed Care Market (Medicare, Medicaid, and Private Health Insurance): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

Date: 29, March 2022 | Pages: 92 | Price : $1250 | Format : Pdf

The US health expenditure is forecasted to reach US$5.75 trillion in 2026, experiencing growth at a CAGR of 5.57% during the period spanning from 2022 to 2026. The national health expenditure by source of funds can be segmented as follows: Managed care, out of pocket, Investments and Others. In 2021, the dominant share was held by managed care segment. This was being followed by out of pocket, ..

Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

Date: 23, March 2022 | Pages: 96 | Price : $1400 | Format : Pdf

The global RNAi therapeutics market is expected to record a value of US$1.15 billion in 2026, progressing at a CAGR of 10.19%, over the period 2022-2026. Factors such as rising utilization in oncology pharmaceuticals, accelerating growth rates of infectious diseases, enlarging geriatric population, increasing prevalence of neurodegenerative disorders and progress in collaborations and associate ..

Global Interventional Pulmonology Market: Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

Date: 11, March 2022 | Pages: 99 | Price : $1400 | Format : Pdf

The global interventional pulmonology market is forecasted to reach US$4.68 billion in 2026, rising at a CAGR of 5.84%, for the time period of 2022-2026. Factors such as growing incidence of lung cancer, rising CO2 emission, expansion of medical device industry, surging COPD mortality rate, increasing elderly population and increasing public awareness would drive the growth of the market. Howev ..